Improving Outcomes for ESRD Patients: Shifting the Quality Paradigm
نویسندگان
چکیده
منابع مشابه
Outcomes research: shifting the dominant research paradigm in physical therapy.
This article discusses outcomes research in physical therapy and places its conceptual roots within the work on quality-of-care assessment. An argument is advanced that the outcomes research movement in medicine has stimulated clinical researchers in physical therapy to address disability outcomes in addition to traditional impairment outcomes. If physical therapy clinical research moves beyond...
متن کاملStrategies for improving long-term survival in patients with ESRD.
In 2003, more than 320,000 people in the United States were receiving dialysis for ESRD, with predicted increases to 650,000 by 2010 and 2 million by 2030. Mortality from cardiovascular disease (CVD) in patients with ESRD is 10 to 30 times higher than in the general population. The exact mechanism of accelerated CVD in patients with kidney disease is unknown. Treatment costs for ESRD are in exc...
متن کاملImproving the Care of ESRD Patients: A Success Story
Medicare's health care quality improvement program (HCQIP) is a national effort to improve beneficiaries' quality of care. The end stage renal disease (ESRD) HCQIP was implemented in 1994 in response to criticism about the poor quality of care received by ESRD patients. Quality improvement efforts initiated by the ESRD Networks and dialysis providers in response to the HCQIP have demonstrated s...
متن کاملShifting the Parallel Programming Paradigm
Multicore computer architectures are now the standard for desktop computers, high-end servers and personal laptops. Due to the multicore shift in computer architecture, software engineers must write multithreaded programs to harness the resources of these parallel machines. Unfortunately, today’s parallel programming techniques are difficult to reason about, highly error-prone and challenging t...
متن کاملParadigm Shift or Shifting Paradigm for Type 1 Diabetes
The age of onset of type 1A diabetes is now immunologically predictable (1). Either because of a lack of sufficient understanding of the pathogenesis of type 1A (immune-mediated) diabetes or a lack of effective therapeutics directed at relevant pathogenic pathways (or both), we cannot yet prevent this disease (2). The article by Liu et al. (3) in this issue of Diabetes addresses both issues in ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Journal of the American Society of Nephrology
سال: 2013
ISSN: 1555-9041,1555-905X
DOI: 10.2215/cjn.05980613